| Literature DB >> 35676751 |
Eleni Aloupogianni1, Masahiro Ishikawa2, Naoki Kobayashi2, Takashi Obi1,3.
Abstract
SIGNIFICANCE: Skin cancer is one of the most prevalent cancers worldwide. In the advent of medical digitization and telepathology, hyper/multispectral imaging (HMSI) allows for noninvasive, nonionizing tissue evaluation at a macroscopic level. AIM: We aim to summarize proposed frameworks and recent trends in HMSI-based classification and segmentation of gross-level skin tissue. APPROACH: A systematic review was performed, targeting HMSI-based systems for the classification and segmentation of skin lesions during gross pathology, including melanoma, pigmented lesions, and bruises. The review adhered to the 2020 Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. For eligible reports published from 2010 to 2020, trends in HMSI acquisition, preprocessing, and analysis were identified.Entities:
Keywords: classification; gross pathology; hyperspectral; medical image processing; skin lesions
Mesh:
Year: 2022 PMID: 35676751 PMCID: PMC9174598 DOI: 10.1117/1.JBO.27.6.060901
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.758
Fig. 1Spectra of the extinction coefficient for the three main chromophores of skin tissue. Reconstruction using data from Ref. 28.
Fig. 2Flowchart of publication selection for this systematic review.
List of eligible studies.
| Ref. | Range (nm) | Channels | Dataset size | Validation | Tissue |
|---|---|---|---|---|---|
|
| 400 to 1000 | 162 | 23 subjects | hist. |
|
|
| 405 to 970 | 19 | 96 lesions | derm. |
|
|
| VIS-NIR | N/A | 1211 lesions | mult. |
|
|
| N/A | 10 | 1632 lesions | derm. |
|
|
| 450 to 950 | 50 | 81 lesions | hist. |
|
|
| 450 to 950 | 50 | 82 lesions | derm. |
|
|
| 380 to 780 | 124 | 24 subjects | hist. |
|
|
| 380 to 780 | 124 | 27 subjects | hist. |
|
|
| 400 to 1100 | 71 | 26 lesions | hist. |
|
|
| 380 to 780 | 124 | 20 subjects | hist. |
|
|
| 540 to 950 | 3 | 3 lesions | derm. |
|
|
| 1000 to 2400 | 140 | 1 subject | other |
|
|
| 360 to 1000 | 1127 | 64 subjects | mult. |
|
|
| 500 to 850 | 71 | 52 lesions | derm. |
|
|
| 450 to 990 | 55 | 32 lesions | hist. |
|
|
| 380 to 780 | 124 | 80 subjects | hist. |
|
|
| 500 to 850 | 71 | 19 subjects | derm. |
|
|
| 400 to 982 | 8 | 18 lesions | hist. |
|
|
| 430 to 950 | 10 | 6 lesions | derm. |
|
|
| 500 to 885 | 76 | 8 lesions | hist. |
|
|
| 450 to 750 | 61 | 4 lesions | N/A | Both |
|
| 450 to 750 | 61 | 45 subjects | hist. |
|
|
| 540 to 950 | 51 | 126 lesions | derm. |
|
|
| 500 to 850 | 71 | 32 lesions | hist. |
|
|
| 400 to 720 | 33 | 26 subjects | hist. |
|
|
| N/A | 10 | 360 lesions | hist. |
|
|
| N/A | N/A | N/A | N/A | N/A |
|
| 414 to 995 | 8 | 429 lesions | derm. |
|
|
| 450 to 950 | 50 | 124 lesions | N/A |
|
|
| 345 to 1040 | N/A | N/A | N/A |
|
|
| 500 to 850 | 71 | 16 lesions | hist. |
|
|
| 450 to 630 | 7 | 10 subjects | derm. |
|
|
| 450 to 750 | 125 | 49 lesions | derm. |
|
|
| 450 to 780 | 34 | 4 subjects | derm. |
|
|
| 450 to 750 | 125 | 76 lesions | derm. |
|
|
| 398 to 757 | 84 | 619 lesions | hist. |
|
|
| 398 to 757 | 84 | 619 lesions | hist. |
|
Note: N/A, not available; derm., dermatology,; hist., histology,; mult., multidisciplinary. Items are ordered according to publication year.
Fig. 3Example of the structure of acquired MSI (left) and HSI (right) data cubes.
Fig. 4The core components of an HMSI system. It includes a camera sensor, a light source, and two polarizers in cross Nicols geometry (one in front of the camera and one in front of the light source). To accommodate this schematic, the light source can be mounted on a ring part.
Overview of HSI systems.
| Range (nm) | Step (nm) | Res. (px) | Density | Area | Duration | Port. |
|---|---|---|---|---|---|---|
| VNIR 1600 (Norsk Elektro Optikk AS, Norway) | ||||||
| Push-broom scanning. Distance 1 m from target surface. | ||||||
| 400 to 1000 | 3.7 | N/A | N/A | N/A | N/A | No |
| N/A (Galderma R&D, Switzerland) | ||||||
| 405 to 970 | 25 |
| N/A | N/A | N/A | N/A |
| SIAscope V (MedX Health, Canada)) | ||||||
| Commercial system in circulation. End-to-end imaging to diagnosis. | ||||||
| N/A | N/A | N/A | N/A | N/A |
| Yes |
| Nuance EX (CRi, USA) | ||||||
| 450 to 950 | 10 | N/A |
| N/A | 2 to 5 min | No |
| Custom MSI-2 (Mitaka Kohki, Japan) | ||||||
| Line scanning. | ||||||
| 380 to 780 | 2.4 |
|
|
| 20 s | No |
| Custom ( | ||||||
| Distance 20 cm from target surface. | ||||||
| 650 to 1100 | 10 | N/A | N/A |
| N/A | Yes |
| SWIR (Specim, Finland) | ||||||
| Line scanning. Target on movable tray. | ||||||
| 1000 to 2400 | 10 |
|
| N/A | N/A | No |
| AvaSpec 2048 (Avantes, Netherlands) | ||||||
| Optical fiber connected to probe at 5 mm from target surface. | ||||||
| 360 to 1000 | 0.6 to 0.53 | N/A | N/A |
| N/A | N/A |
| FPI VIS-VNIR (VTT, Finland) | ||||||
| Snapshot scanning. Distance 4 cm from target surface. | ||||||
| 500 to 850 | 5 to 10 |
| N/A |
|
| Yes |
| Custom ( | ||||||
| Overhead camera away from the target surface. | ||||||
| 450 to 750 | 5 |
| N/A |
| N/A | No |
| Custom ( | ||||||
| Overhead camera away from the target surface. | ||||||
| 400 to 720 | 10 | N/A | N/A | N/A | 4 min | No |
| USB4000 (Ocean Optics, USA) | ||||||
| 345 to 1040 | 1.5 to 2.3 | N/A | N/A | N/A | N/A | N/A |
| UHD 185 (Cubert GmbH, Germany) | ||||||
| Attached directly on the target surface with contact ring. | ||||||
| 450 to 750 | 8 |
| N/A |
| 250 ms | Yes |
| IMPULSO (PUCP, Peru) | ||||||
| 450 to 780 | 10 |
| N/A |
| N/A | N/A |
Note: N/A, not available; Res., resolution; density, pixel density; area, capture area; port., portability.
Overview of MSI systems.
| Range (nm) | Channels | Res. (px) | Density | Area | Duration | Port. |
|---|---|---|---|---|---|---|
| MelaFind (MELA Sciences, SUA) | ||||||
| Commercial system, discontinued. End-to-end imaging to diagnosis. | ||||||
| 430 to 950 | 10 | N/A | N/A | N/A | N/A | No |
| Custom ( | ||||||
| Sequential capturing at each filter. | ||||||
| VIS | 8 | N/A | N/A | N/A | N/A | N/A |
| Custom ( | ||||||
| Sequential capturing at each LED. | ||||||
| 414 to 995 | 8 |
| N/A |
| 40 s | Yes |
| Custom ( | ||||||
| Sequential capturing at each LED. | ||||||
| VIS-NIR | 4 |
| N/A |
| 40 s | Yes |
| Custom ( | ||||||
| Sequential capturing at each LED. | ||||||
| 450 to 630 | 9 |
| N/A | N/A |
| No |
Note: N/A; not available; Res.; resolution; density, pixel density; area, capture area; port., portability.
Fig. 5Flowchart of a typical processing scheme for HMSI spectral signatures. Dashed lines indicate optional steps, while full lines indicate required steps.
Fig. 6Ex vivo spectra for PSL, adapted from unpublished work by Ref. 71. The blue line represents the average. Depending on the tissue type, spectral signatures of each pixel differ in shape and value. Spectral signatures for mucinous carcinoma and Bowen’s disease are smoothly rising lines, whereas for BCC there is a sudden slope around 570 nm, consistent with the local maximum of hemoglobin absorption. Reproduced with permission.
Performance of eligible studies.
| Ref. | Method | Scale | Acc. | Sens. | Spec. | Task |
|---|---|---|---|---|---|---|
|
|
| Pixel | N/A | N/A | N/A | seg. |
|
|
| Pixel | 100.0% | N/A | N/A | seg. |
|
| Scoring algorithm | Image | N/A | 44.0% | 95.0% | clf. |
|
| MSDSLA | Image | N/A | 98.4% | 9.9% | clf. |
|
| Discrimination index | Patch | N/A | 86.0% | 2.0% | clf. |
|
| Discrimination index | Patch | N/A | N/A | N/A | clf. |
|
| Discrimination index | Image | N/A | 90.0% | 84.0% | clf. |
|
| Discrimination index | Image | N/A | 100.0% | 94.4% | clf. |
|
|
| ROI | 88.5% | 100.0% | 85.0% | clf. |
|
| Discrimination index | Image | N/A | 92.3% | 85.7% | clf. |
|
| Discrimination index | ROI | N/A | N/A | N/A | clf. |
|
| CDA | ROI | 90.2% | N/A | N/A | clf. |
|
|
| Pixel | N/A | 97.0% | 96.0% | clf. |
|
| Multilayer perceptron | Pixel | N/A | 100.0% | N/A | seg. |
|
|
| ROI | N/A | 100.0% | 72.0% | clf. |
|
| Discrimination index | Image | N/A | 96.0% | 87.0% | clf. |
|
|
| Pixel | 94.7% | N/A | N/A | seg. |
|
| Pixel | 96.0% | N/A | N/A | clf. | |
|
| MSDSLA | Image | N/A | 83.0% | 76.0% | clf. |
|
|
| Patch | N/A | N/A | N/A | seg. |
|
| Discrimination index | N/A | Pixel | N/A | N/A | seg. |
|
|
| N/A | Pixel | 84.0% | 87.0% | seg. |
|
| Threshold classifier | Pixel | 96.8% | 100.0% | 95.7% | clf. |
|
|
| Pixel | N/A | 90.0% | 86.3% | seg. |
|
|
| Pixel | N/A | N/A | N/A | seg. |
|
| MSDSLA | Image | N/A | 100.0% | 5.5% | clf. |
|
| Meta-analysis | N/A | N/A | 92.9% | 43.6% | clf. |
|
|
| Image | N/A | 91.3% | 54.5% | clf. |
|
|
| Pixel | 96.0% | 96.8% | 95.7% | seg. |
|
| Reflectance average | N/A | N/A | N/A | N/A | clf. |
|
|
| Pixel | 75.0% | N/A | N/A | seg. |
|
|
| Pixel | 83.3% | N/A | N/A | seg. |
|
|
| Pixel | 75.3% | N/A | N/A | clf. |
|
| ANN | Pixel | N/A | 91.6% | N/A | clf. |
|
|
| Pixel | N/A | 87.5% | 100.0% | seg. |
|
|
| Image | 77.2% | 72.3% | 81.2% | clf. |
|
| Image | N/A | 79.9% | 82.4% | clf. |
Note: N/A, not available; seg., segmentation; clf., classification. Other abbreviations are listed in the main text.
Fig. 7Sensitivity against specificity for eligible studies. The size of the marker is proportional to the number of lesions included in the study.
Summary of proposed discrimination indices.
| Target | Index | Reference |
|---|---|---|
| Melanoma versus rest |
| |
| Melanoma versus rest |
|
|
| Melanoma versus rest |
|
|
| Melanoma versus PSL |
|
|
| Neoplasm versus rest |
|
|
| Malignancy versus rest |
|
|
Note: , optical density at wavelength ; , spatial subimage at ; PDF, probability density function. Other abbreviations are listed in the main text.
Fig. 8Example of initial processing for an MM. Spectral signatures from HSI subimages in (a) are used to calculate SAM values in (b). Pseudo-RGB images and SAM angles for MM (left) and benign dermatofibroma (right) are presented in (b). Spectral signatures of the highlighted red points in (b) are shown in comparison to the reference signature of healthy skin in (c). The angles of melanoma signatures are larger than those of dermatofibroma. The blue marks surrounding the melanoma tissue are pathology stains. Adapted from unpublished work by Ref. 71. Reproduced with permission.